Stonvex
Stonvex
StonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest newsβ¦
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview Β· 3 reports / hour Β· No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro βNext report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals β Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
6-factor scoring with sector-relative rank. Updated daily.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
Indicator values from Polygon. Educational only β single- indicator triggers in isolation are not a complete trading signal.
| Date | Open | Close | Ξ | Vol |
|---|---|---|---|---|
| 05-13 | $3.11 | $4.04 | +29.90% | 0.1M |
| 05-14 | $4.04 | $3.94 | -2.48% | 0.0M |
| 05-15 | $3.92 | $4.25 | +8.42% | 0.0M |
| 05-18 | $4.10 | $4.27 | +4.19% | 0.0M |
| 05-19 | $4.24 | $4.57 | +7.78% | 0.0M |
Documents are served directly from sec.gov / the issuer's website β Stonvex does not proxy or store filings.
No sell-side coverage available for BKYI.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fundamentals not available for BKYI.
No fundamental metrics available yet for this ticker β common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.
| Metric | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $4.85M | $3.30M | $1.61M | $6.93M |
Operating Income | $-2.62M | $-1.72M | $-640.64K | $-4.01M |
Net Income | $-2.87M | $-1.17M | $-736.54K | $-4.30M |
EPS (Diluted) | $-0.50 | $-0.36 | $-0.16 | $-2.09 |
Total Assets | $10.11M | $10.52M | $11.18M | $8.62M |
Total Liabilities | $4.07M | $3.66M | $3.66M | $4.84M |
Cash & Equivalents | $2.04M | $2.28M | $3.13M | $437.60K |
Free Cash Flow OCF β CapEx | $-2.85M | $-1.72M | $-839.88K | $-2.93M |
Shares Outstanding | 7.31M | 6.85M | 5.81M | 3.72M |
BIO-KEY INTL INC